Stay updated on NYX-2925 Efficacy & Safety in Fibromyalgia: Clinical Trial
Sign up to get notified when there's something new on the NYX-2925 Efficacy & Safety in Fibromyalgia: Clinical Trial page.

Latest updates to the NYX-2925 Efficacy & Safety in Fibromyalgia: Clinical Trial page
- Check5 days agoChange DetectedA notice at the top of the page says NIH is transitioning from the term “Artificial Intelligence” to “Super Intelligence” under Executive Order 14434.SummaryDifference0.4%

- Check12 days agoChange DetectedThe ClinicalTrials.gov site footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.1%

- Check19 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.7.1 instead of v3.7.0.SummaryDifference0.1%

- Check39 days agoChange DetectedAdded a new revision entry (Revision: v3.7.0) to the study history and removed the older Revision: v3.6.6. This reflects an updated version of the record in the history log.SummaryDifference0.1%

- Check61 days agoChange DetectedA new revision entry v3.6.6 was added to the study's history, replacing the previous v3.6.5.SummaryDifference0.1%

- Check82 days agoChange DetectedVersion updated from v3.6.4 to v3.6.5 in the study record history. This reflects a small, non-data-affecting update to the page content or formatting.SummaryDifference0.1%

Stay in the know with updates to NYX-2925 Efficacy & Safety in Fibromyalgia: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NYX-2925 Efficacy & Safety in Fibromyalgia: Clinical Trial page.